Feasterville-Trevose, Pennsylvania Clinical Trials

A listing of Feasterville-Trevose, Pennsylvania clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 35 clinical trials
UPENN Case Test Trial 13 (Do Not Make Any Changes)

UPENN Case Test Trial 13 (Do Not Make Any Changes)

Abington Neurological Associates- Site Number : 8401065
 (7.5 away) Contact site
  • 0 views
  • 15 May, 2025
  • 1 location
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

cardiovascular disease
body mass index
tirzepatide
dulaglutide
Diabetes & Endocrinology Consultants of Pennsylvania, LLC
 (0.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +650 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

flortaucipir
positron emission tomography
alzheimer's disease
florbetapir
mini-mental state examination
Abington Neurological Associates
 (7.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +85 other locations
Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer

Standard chemoradiation, followed by surgery are standard treatment plan for patients suffering from pancreatic adenocarcinoma. Due to damage to the surrounding healthy tissue caused by standard radiation, this study uses a new type of radiation plan- pulsed low-dose rate (PLDR) radiation , in combination with chemotherapeutic drug, gemcitabine, given weekly …

chemoradiotherapy
celiac disease
kidney function tests
cancer
metastatic pancreatic cancer
Fox Chase Cancer Center
 (7.2 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • 1 location
Buprenorphine for Cancer Pain

This study will evaluate patients on both buprenorphine and full agonist opioids (FAO) to assess for withdrawal symptoms. Patients will be evaluated by clinicians and using validated tools to assess for pain and withdrawal. At the same time, patients will use a CPM Rx application on their phone to track …

Fox Chase Cancer Center
 (7.2 away) Contact site
  • 0 views
  • 13 Jan, 2025
  • 1 location